Publications

Activity of oritavancin against Gram-positive pathogens causing bloodstream infections in the United States over 10 Years: Focus on drug-resistant enterococcal subsets (2010-2019). by Carvalhaes CG, Sader HS, Streit JM, Castanheira M and Mendes RE. published in Antimicrob. Agents Chemother. 2022; 66 (2): e0166721

View publication